Loading…
Reported covered position: STAFF DIR, SENATE LABOR COMMITTEE
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Safeguarding America's Pharmaceuticals Act of 2013
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144) S. 957, Drug Supply Chain Security Act; H.R. 1919 the Safeguarding America's Pharmaceuticals Act of 2013 S. 959, Pharmaceutical Compounding Quality and Accountability Act
MODDERN Cures Act, H.R. 3091 and H.R. 3116.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ELI LILLY AND COMPANY via FOLEY HOAG LLP
2013 · third_quarter · Q3
MODDERN Cures Act, H.R. 3091 and H.R. 3116.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2013 · third_quarter · Q3
Source: Senate LDA
| ORGANOGENESIS INC. |
| 26 |
| 1999–2012 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 24 | 2001–2010 |
| ELI LILLY AND COMPANY | 23 | 2008–2013 |
| STATE OF THE USA | 20 | 2007–2012 |
| PFIZER, INC. | 18 | 2006–2010 |
| AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION | 17 | 2009–2012 |
| XDX INC | 15 | 2006–2012 |
| AMERICAN COLLEGE OF GASTROENTEROLOGY | 13 | 2009–2013 |
| GENENTECH INC | 13 | 2007–2009 |
| BRISTOL-MYERS SQUIBB | 12 | 2007–2010 |
| BIOGEN IDEC INC. | 11 | 2004–2008 |
| CAPELLA UNIVERSITY | 11 | 2001–2006 |
| SCHOLASTIC | 10 | 1999–2006 |
| ACADEMY OF MOLECULAR IMAGING | 7 | 2000–2006 |
| NOVARTIS | 7 | 2003–2007 |
| ADAMAS PHARMACEUTICALS | 6 | 2009–2010 |
| ADVANCED CELL TECHNOLOGY | 6 | 2010–2011 |
| CELL THERAPEUTICS INC | 6 | 2003–2005 |
| MA ASSN OF 766 APPROVED PRIVATE SCHOOLS | 6 | 2001–2003 |
| PARTNERS HEALTHCARE SYSTEM | 6 | 2010–2011 |
| TETHYS BIOSCIENCE | 6 | 2007–2009 |
| EMPI | 5 | 2002–2004 |
| INVERNESS MEDICAL INNOVATIONS | 5 | 2009 |
| ANTIGENICS | 4 | 2001–2002 |
| ASTRAZENECA PHARMACEUTICALS LP | 4 | 2007–2008 |
| BIOGEN | 4 | 2001–2003 |
| CHIMERIX, INC. | 4 | 2012 |
| CHIRON CORP | 4 | 2003–2004 |
| NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 4 | 2006–2007 |
| NX STAGE MEDICAL INC | 4 | 2001–2002 |
| QLT | 4 | 2003–2005 |
| ABBOTT LABORATORIES | 3 | 2007 |
| DENOVIS | 3 | 2001–2002 |
| DOVETAIL HEALTH | 3 | 2011 |
| KLEINER PERKINS CAUFIELD & BYERS | 3 | 2006 |
| MERCK | 3 | 2003–2004 |
| SANOFI-AVENTIS U.S. INC. | 3 | 2007–2008 |
| ARDAIS | 2 | 2001–2002 |
| CATAPULT LEARNING | 2 | 2004 |
| CLEAN HARBORS | 2 | 2001–2002 |
| EISAI CORPORATION OF NORTH AMERICA | 2 | 2009 |
| GUILFORD PHARMACEUTICALS | 2 | 2003–2004 |
| INTL ONCOLOGY NETWORK | 2 | 2004 |
| MASSACHUSETTS DEVELOPMENT FINANCE AGENCY | 2 | 1999 |
| NETWORK APPLIANCE | 2 | 2001 |
| NEWBURY COLLEGE | 2 | 2003 |
| TELADOC INC | 2 | 2012 |
| BOSTON MEDICAL CENTER | 1 | 2006 |
| DANA FARBER CANCER INST | 1 | 1999 |
| GLAXOSMITHKLINE | 1 | 2008 |
| IDEC PHARMACEUTICALS CORP | 1 | 2003 |
| NELLIE MAE (NEW ENGLAND EDUCATIONA LOAN MARKETING CORP) | 1 | 1999 |
| OPTIMER PHARMACEUTICALS, INC. | 1 | 2012 |
| TASK FORCE ON SCIENCE HEALTH CARE | 1 | 2000 |
| TRUST INSURANCE CO | 1 | 1999 |
MODDERN Cures Act, H.R. 3091 and H.R. 3116.
H.R. 3497, the MODDERN Cures Act.
Removing Barriers to Adoption and Supporting Families Act of 2013
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: FOLEY HOAG LLP
Colorectal Cancer Medicare and Reimbursement Issues; Screen Act--S. 1511 Supporting Colorectal Examination Now Act; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) The American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8
Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144) S. 957, Drug Supply Chain Security Act; H.R. 1919 the Safeguarding America's Pharmaceuticals Act of 2013 S. 959, Pharmaceutical Compounding Quality and Accountability Act
Pharmaceutical Quality, Security, and Accountability Act
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144) S. 957, Drug Supply Chain Security Act; H.R. 1919 the Safeguarding America's Pharmaceuticals Act of 2013 S. 959, Pharmaceutical Compounding Quality and Accountability Act
Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011.
American Taxpayer Relief Act of 2012
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: FOLEY HOAG LLP
Colorectal Cancer Medicare and Reimbursement Issues; Screen Act--S. 1511 Supporting Colorectal Examination Now Act; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) The American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8
American Taxpayer Relief Act of 2012
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8 Regulation of laboratory-developed tests.
American Taxpayer Relief Act of 2012
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8
Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8
American Taxpayer Relief Act of 2012
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8
American Taxpayer Relief Act of 2012
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8
American Taxpayer Relief Act of 2012
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8
Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8
S.3187, Food and Drug Administration Safety and Innovation Act; Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
FDA legislation and regulatory implementation issues. Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011ug User Fee Act.
FDA legislation and regulatory implementation issues. Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
Regenerative Medicine Promotion Act of 2011
Client: ORGANOGENESIS INC. · Firm: FOLEY HOAG LLP
Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment for drugs and biologics)
Regenerative Medicine Promotion Act of 2011
Client: ORGANOGENESIS INC. · Firm: FOLEY HOAG LLP
Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment for drugs and biologics)
Regenerative Medicine Promotion Act of 2011
Client: ORGANOGENESIS INC. · Firm: FOLEY HOAG LLP
Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment for drugs and biologics)
Regenerative Medicine Promotion Act of 2011
Client: ORGANOGENESIS INC. · Firm: FOLEY HOAG LLP
Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment for drugs and biologics)
Regenerative Medicine Promotion Act of 2011
Client: ORGANOGENESIS INC. · Firm: FOLEY HOAG LLP
Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment for drugs and biologics)
Medicare Orthotics and Prosthetics Improvement Act of 2011
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773).
Medicare Orthotics and Prosthetics Improvement Act of 2011
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773).
Medicare Orthotics and Prosthetics Improvement Act of 2011
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773).
Medicare Orthotics and Prosthetics Improvement Act of 2011
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773).
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: CHIMERIX, INC. · Firm: FOLEY HOAG LLP
Congressional outreach regarding biodefense medical countermeasures for smallpox. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 2405 and S. 1855). FY2013 HHS/BARDA funding (Senate Labor-HHS Appropriations and House Labor-HHS Appropriations). Biomedical Advanced Research and Development Authority (BARDA)
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: CHIMERIX, INC. · Firm: FOLEY HOAG LLP
Congressional outreach regarding biodefense medical countermeasures for smallpox. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 2405 and S. 1855). FY2013 HHS/BARDA funding (Senate Labor-HHS Appropriations and House Labor-HHS Appropriations). Biomedical Advanced Research and Development Authority (BARDA)
Congressional outreach regarding biodefense medical countermeasures for smallpox. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 2504 and S. 1855). FY2013 HHS/BARDA funding (Senate Labor-HHS Appropriations and House Labor-HHS Appropriations).
Colorectal Cancer Medicare and Reimbursement Issues; H.R. 3198 Supporting Colorectal Examination and Education Now Act of 2011; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152).
H.R. 3497, the MODDERN Cures Act.
S. 3187 Food and Drug Administration Safety and Administration Act H.R. 5651 Food and Drug Administration Reform Act Work to educate Congress on telehealth and telemedicine issues in the Prescription Drug User Fee Act Amendments.
S. 3187 Food and Drug Administration Safety and Administration Act H.R. 5651 Food and Drug Administration Reform Act Work to educate Congress on telehealth and telemedicine issues in the Prescription Drug User Fee Act Amendments.
Regenerative Medicine Promotion Act of 2011
Client: ORGANOGENESIS INC. · Firm: FOLEY HOAG LLP
Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment)
Regenerative Medicine Promotion Act of 2011
Client: ORGANOGENESIS INC. · Firm: FOLEY HOAG LLP
Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment for drugs and biologics)
Medicare Orthotics and Prosthetics Improvement Act of 2011
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773)
Medicare Orthotics and Prosthetics Improvement Act of 2011
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773)
Medicare Orthotics and Prosthetics Improvement Act of 2011
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773)
Generating Antibiotic Incentives Now Act of 2011
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act
H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act 2011 (Medicare Part D) (Medicare coverage policy for chronic renal disease); Medicare Part B reimbursement and coverage of dialysis products.
To amend title 10, United States Code, to authorize the Secretary of Defense (and the Secretary of Homeland Security in the case of the Coast Guard) to issue, at no cost to the United States, a military service identification card to persons who served in the Armed Forces.
Client: ADVANCED CELL TECHNOLOGY · Firm: FOLEY HOAG LLP
HR 4808 (Stem Cell Research Advancement Act of 2009) HR 3293 (Departments of Labor, Health and Human Services, and Education Appropriations Bill)
To amend section 310 of the Supplemental Appropriations Act, 2009 to extend the period of time during which claims for retroactive stop-loss special pay may be submitted.
Client: ELI LILLY AND COMPANY · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
To amend section 310 of the Supplemental Appropriations Act, 2009 to extend the period of time during which claims for retroactive stop-loss special pay may be submitted.
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act; Generating Antibiotic Incentives Now (GAIN Act)
Protecting Consumer Access to Generic Drugs Act of 2009
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act; Generating Antibiotic Incentives Now (GAIN Act)
Protecting Consumer Access to Generic Drugs Act of 2009
Client: ELI LILLY AND COMPANY · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
Stem Cell Research Advancement Act of 2009
Client: ADVANCED CELL TECHNOLOGY · Firm: FOLEY HOAG LLP
HR 4808 (Stem Cell Research Advancement Act of 2009) HR 3293 (Departments of Labor, Health and Human Services, and Education Appropriations Bill)
Stem Cell Research Advancement Act of 2009
Client: ADVANCED CELL TECHNOLOGY · Firm: FOLEY HOAG LLP
H.R. 4808 (Stem Cell Research Advancement Act of 2009)
Stem Cell Research Advancement Act of 2009
Client: ADVANCED CELL TECHNOLOGY · Firm: FOLEY HOAG LLP
H.R. 4808 (Stem Cell Research Advancement Act of 2009)
Patient Access to Critical Lab Tests Act
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Preserve Access to Affordable Generics Act
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act; Generating Antibiotic Incentives Now (GAIN Act)
Preserve Access to Affordable Generics Act
Client: ELI LILLY AND COMPANY · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act; Generating Antibiotic Incentives Now (GAIN Act)
Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); American Jobs and Closing Tax Loopholes Act of 2010 (H.R. 4213); Domestic HIV Policy Issues (H.R. 1429-Stop AIDS in Prison Act of 2009; Hepatitis B Funding for Screening and Linkage to Care Programs
Protecting Consumer Access to Generic Drugs Act of 2009
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
Protecting Consumer Access to Generic Drugs Act of 2009
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
Protecting Consumer Access to Generic Drugs Act of 2009
Client: ELI LILLY AND COMPANY · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
Protecting Consumer Access to Generic Drugs Act of 2009
Client: PFIZER INC · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
Protecting Consumer Access to Generic Drugs Act of 2009
Client: PFIZER INC · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
Medicare Orthotics and Prosthetics Improvement Act of 2009
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act of 2009 (H.R. 2479); Prosthetic and Custom Orthotic Parity Act of 2009 (H.R. 2575 and S. 3223)
Medicare Orthotics and Prosthetics Improvement Act of 2009
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act of 2009 (H.R. 2479); Prosthetic and Custom Orthotic Parity Act of 2009 (H.R. 2575 and S. 3223)
Medicare Orthotics and Prosthetics Improvement Act of 2009
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act of 2009 (H.R. 2479); Prosthetic and Custom Orthotic Parity Act of 2009 (H.R. 2575 and S. 3223)
Prosthetic and Custom Orthotic Parity Act of 2009
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act of 2009 (H.R. 2479); Prosthetic and Custom Orthotic Parity Act of 2009 (H.R. 2575 and S. 3223)
Prosthetic and Custom Orthotic Parity Act of 2009
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act of 2009 (H.R. 2479); Prosthetic and Custom Orthotic Parity Act of 2009 (H.R. 2575 and S. 3223)
Prosthetic and Custom Orthotic Parity Act of 2009
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act of 2009 (H.R. 2479); Prosthetic and Custom Orthotic Parity Act of 2009 (H.R. 2575 and S. 3223)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
Client: ADVANCED CELL TECHNOLOGY · Firm: FOLEY HOAG LLP
HR 4808 (Stem Cell Research Advancement Act of 2009) HR 3293 (Departments of Labor, Health and Human Services, and Education Appropriations Bill)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
Client: ADVANCED CELL TECHNOLOGY · Firm: FOLEY HOAG LLP
HR 4808 (Stem Cell Research Advancement Act of 2009) HR 3293 (Departments of Labor, Health and Human Services, and Education Appropriations Bill)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
Client: ADVANCED CELL TECHNOLOGY · Firm: FOLEY HOAG LLP
HR 4808 (Stem Cell Research Advancement Act of 2009) HR 3293 (Departments of Labor, Health and Human Services, and Education Appropriations Bill)
Stem Cell Research Advancement Act of 2009
Client: ADVANCED CELL TECHNOLOGY · Firm: FOLEY HOAG LLP
HR 4808 (Stem Cell Research Advancement Act of 2009) HR 3293 (Departments of Labor, Health and Human Services, and Education Appropriations Bill)
Stem Cell Research Advancement Act of 2009
Client: ADVANCED CELL TECHNOLOGY · Firm: FOLEY HOAG LLP
HR 4808 (Stem Cell Research Advancement Act of 2009) HR 3293 (Departments of Labor, Health and Human Services, and Education Appropriations Bill)
Stem Cell Research Advancement Act of 2009
Client: ADVANCED CELL TECHNOLOGY · Firm: FOLEY HOAG LLP
HR 4808 (Stem Cell Research Advancement Act of 2009) HR 3293 (Departments of Labor, Health and Human Services, and Education Appropriations Bill)
Genomics and Personalized Medicine Act of 2010
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152);Genomics & Personalized Medicine Act H.R. 5440
Genomics and Personalized Medicine Act of 2010
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152);Genomics & Personalized Medicine Act H.R. 5440
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: PFIZER INC · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: PFIZER INC · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: ELI LILLY AND COMPANY · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
To provide for the mandatory recall of adulterated or misbranded drugs.
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
HR 759 Food and Drug Administration Globalization Act of 2009; S. 882 The Drug and Device Accountability Act of 2009; S. 882 The Drug and Device Accountability Act of 2009; H.R.5740, To provide for the mandatory recall of adulterated or misbranded drugs.
Food and Drug Administration Globalization Act of 2009
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
HR 759 Food and Drug Administration Globalization Act of 2009; S. 882 The Drug and Device Accountability Act of 2009; S. 882 The Drug and Device Accountability Act of 2009; H.R.5740, To provide for the mandatory recall of adulterated or misbranded drugs.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152);Genomics & Personalized Medicine Act H.R. 5440
Patient Access to Critical Lab Tests Act
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); American Jobs and Closing Tax Loopholes Act of 2010 (H.R. 4213)
Patient Access to Critical Lab Tests Act
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory- developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act H.R. 3590
Patient Access to Critical Lab Tests Act
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); American Jobs and Closing Tax Loopholes Act of 2010 (H.R. 4213)
Patient Access to Critical Lab Tests Act
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152);Genomics & Personalized Medicine Act H.R. 5440
Supporting ColoRectal Examination and Education Now (SCREEN) Act of 2009
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: FOLEY HOAG LLP
Colorectal Cancer Medicare and Reimbursement Issues; Screen Act--S. 1511 Supporting Colorectal Examination Now Act; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); American Jobs and Closing Tax Loopholes Act of 2010 (H.R. 4213)
Supporting ColoRectal Examination and Education Now (SCREEN) Act of 2009
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: FOLEY HOAG LLP
Colorectal Cancer Medicare and Reimbursement Issues; Screen Act--S. 1511 Supporting Colorectal Examination Now Act; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); American Jobs and Closing Tax Loopholes Act of 2010 (H.R. 4213)
Prosthetics and Custom Orthotics Parity Act of 2010
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act of 2009 (H.R. 2479); Prosthetic and Custom Orthotic Parity Act of 2009 (H.R. 2575 and S. 3223)
Prosthetics and Custom Orthotics Parity Act of 2010
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act of 2009 (H.R. 2479); Prosthetic and Custom Orthotic Parity Act of 2009 (H.R. 2575 and S. 3223)
Prosthetics and Custom Orthotics Parity Act of 2010
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act of 2009 (H.R. 2479); Prosthetic and Custom Orthotic Parity Act of 2009 (H.R. 2575 and S. 3223)
Preserve Access to Affordable Generics Act
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
Preserve Access to Affordable Generics Act
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
Preserve Access to Affordable Generics Act
Client: ELI LILLY AND COMPANY · Firm: FOLEY HOAG LLP
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
Medicare Part B payment for drugs.
Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2013 · third_quarter · Q3
Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2013 · third_quarter · Q3
Reimbursement for molecular diagnostics and fee schedule assignment of genetic tests
Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8 Regulation of laboratory-developed tests.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2013 · third_quarter · Q3
Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")
Medicare Part D Prescription Drug Benefit; Medicare coverage policy for chronic renal disease; Medicare Part B payment and coverage of dialysis products; Congressional deficit reduction negotiations, and implementation of the Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2013 · second_quarter · Q2
Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")
Medicare Part D Prescription Drug Benefit; Medicare coverage policy for chronic renal disease; Medicare Part B payment and coverage of dialysis products; Congressional deficit reduction negotiations, and implementation of the Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via FOLEY HOAG LLP
2013 · second_quarter · Q2
H.R. 3497, the MODDERN Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2013 · second_quarter · Q2
Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144) S. 957, Drug Supply Chain Security Act; H.R. 1919 the Safeguarding America's Pharmaceuticals Act of 2013 S. 959, Pharmaceutical Compounding Quality and Accountability Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2013 · second_quarter · Q2
Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8
Reimbursement for molecular diagnostics and fee schedule assignment of genetic tests; Regulation of laboratory-developed tests
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2013 · second_quarter · Q2
Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")
Medicare Part D Prescription Drug Benefit; Medicare coverage policy for chronic renal disease; Medicare Part B payment and coverage of dialysis products; Congressional deficit reduction negotiations, and implementation of the Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2013 · first_quarter · 1A
Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8
Reimbursement for molecular diagnostics and fee schedule assignment of genetic tests; Regulation of laboratory-developed tests
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2013 · first_quarter · Q1
Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8
Reimbursement for molecular diagnostics and fee schedule assignment of genetic tests; Regulation of laboratory-developed tests
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GILEAD SCIENCES INC via FOLEY HOAG LLP
2013 · first_quarter · 1A
Domestic HIV Policy Issues; Hepatitis B Funding for Screening and Linkage to Care Programs; Budget Control Act of 2011(P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC via FOLEY HOAG LLP
2013 · first_quarter · Q1
Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2013 · first_quarter · Q1
Medicare Part D Prescription Drug Benefit; Medicare coverage policy for chronic renal disease; Medicare Part B payment and coverage of dialysis products; Congressional deficit reduction negotiations, and implementation of the Budget Control Act of 2011 (P.L. 112-25)
Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via FOLEY HOAG LLP
2013 · first_quarter · Q1
Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2013 · first_quarter · Q1
Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2013 · first_quarter · Q1
Reimbursement for molecular diagnostics and fee schedule assignment of genetic tests; Regulation of laboratory-developed tests
Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2013 · first_quarter · Q1
Medicare Part D Prescription Drug Benefit; Medicare coverage policy for chronic renal disease; Medicare Part B payment and coverage of dialysis products; Congressional deficit reduction negotiations, and implementation of the Budget Control Act of 2011 (P.L. 112-25)
Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2013 · first_quarter · 1T
Colorectal Cancer Medicare and Reimbursement Issues; Screen Act--S. 1511 Supporting Colorectal Examination Now Act; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) The American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8
Medicare Reimbursement regarding SGR and ASC payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2012 · fourth_quarter · 4A
Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2012 · fourth_quarter · Q4
Reimbursement for molecular diagnostics and fee schedule assignment of genetic tests; Regulation of laboratory-developed tests
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GILEAD SCIENCES INC via FOLEY HOAG LLP
2012 · fourth_quarter · Q4
Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2012 · fourth_quarter · Q4
S.3187, Food and Drug Administration Safety and Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via FOLEY HOAG LLP
2012 · fourth_quarter · Q4
Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2012 · fourth_quarter · Q4
Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHIMERIX, INC. via FOLEY HOAG LLP
2012 · fourth_quarter · Q4
Congressional outreach regarding biodefense medical countermeasures for smallpox. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 2405 and S. 1855). FY2013 HHS/BARDA funding (Senate Labor-HHS Appropriations and House Labor-HHS Appropriations). Biomedical Advanced Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2012 · fourth_quarter · Q4
Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act; Budget Control Act of 2011 (P.L. 112-25)
Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION via FOLEY HOAG LLP
2012 · fourth_quarter · 4T
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2012 · fourth_quarter · Q4
Medicare Reimbursement regarding SGR and ASC payments.
Colorectal Cancer Medicare and Reimbursement Issues; Screen Act--S. 1511 Supporting Colorectal Examination Now Act; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHIMERIX, INC. via FOLEY HOAG LLP
2012 · third_quarter · Q3
Congressional outreach regarding biodefense medical countermeasures for smallpox. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 2405 and S. 1855). FY2013 HHS/BARDA funding (Senate Labor-HHS Appropriations and House Labor-HHS Appropriations). Biomedical Advanced Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GILEAD SCIENCES INC via FOLEY HOAG LLP
2012 · third_quarter · Q3
Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2012 · third_quarter · Q3
S.3187, Food and Drug Administration Safety and Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via FOLEY HOAG LLP
2012 · third_quarter · Q3
H.R. 3497, the MODDERN Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2012 · third_quarter · Q3
S.3187, Food and Drug Administration Safety and Innovation Act; Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2012 · third_quarter · Q3
Reimbursement for molecular diagnostics and fee schedule assignment of genetic tests; Regulation of laboratory-developed tests
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2012 · third_quarter · Q3
Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)
Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act; Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION via FOLEY HOAG LLP
2012 · third_quarter · Q3
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2012 · third_quarter · Q3
Colorectal Cancer Medicare and Reimbursement Issues; H.R. 3198 Supporting Colorectal Examination and Education Now Act of 2011; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152).
Medicare Reimbursement regarding SGR and ASC payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANOGENESIS INC. via FOLEY HOAG LLP
2012 · second_quarter · 2@
Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment for drugs and biologics)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANOGENESIS INC. via FOLEY HOAG LLP
2012 · first_quarter · 1A
Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment for drugs and biologics)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2012 · second_quarter · 2A
Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)
Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act; Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANOGENESIS INC. via FOLEY HOAG LLP
2012 · second_quarter · 2@
Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment for drugs and biologics)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TELADOC INC via FOLEY HOAG LLP
2012 · second_quarter · Q2
S. 3187 Food and Drug Administration Safety and Administration Act H.R. 5651 Food and Drug Administration Reform Act Work to educate Congress on telehealth and telemedicine issues in the Prescription Drug User Fee Act Amendments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANOGENESIS INC. via FOLEY HOAG LLP
2012 · second_quarter · 2T
Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment for drugs and biologics)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHIMERIX, INC. via FOLEY HOAG LLP
2012 · second_quarter · Q2
Congressional outreach regarding biodefense medical countermeasures for smallpox. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 2504 and S. 1855). FY2013 HHS/BARDA funding (Senate Labor-HHS Appropriations and House Labor-HHS Appropriations).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC via FOLEY HOAG LLP
2012 · second_quarter · Q2
Domestic HIV Policy Issues; Hepatitis B Funding for Screening and Linkage to Care Programs; Budget Control Act of 2011(P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2012 · second_quarter · Q2
FDA legislation and regulatory implementation issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via FOLEY HOAG LLP
2012 · second_quarter · Q2
FDA legislation and regulatory implementation issues. Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011ug User Fee Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2012 · second_quarter · Q2
FDA legislation and regulatory implementation issues. Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2012 · second_quarter · Q2
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); Budget Control Act of 2011(P.L. 112-25).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2012 · second_quarter · Q2
Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)
Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act; Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION via FOLEY HOAG LLP
2012 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2012 · second_quarter · Q2
Colorectal Cancer Medicare and Reimbursement Issues; Screen Act--S. 1511 Supporting Colorectal Examination Now Act; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152).
Medicare Reimbursement regarding SGR and ASC payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPTIMER PHARMACEUTICALS, INC. via FOLEY HOAG LLP
2012 · second_quarter · RA
Medicare drug reimbursement.
TELADOC INC via FOLEY HOAG LLP
2012 · second_quarter · RR
S. 3187 Food and Drug Administration Safety and Administration Act H.R. 5651 Food and Drug Administration Reform Act Work to educate Congress on telehealth and telemedicine issues in the Prescription Drug User Fee Act Amendments.
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2012 · first_quarter · Q1
Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHIMERIX, INC. via FOLEY HOAG LLP
2012 · second_quarter · RR
Implementation of Project BioShield Act and the Pandemic and All-Hazards Preparedness Act (PAHPA). Education and awareness on smallpox medical countermeasures (MCM).
2012 · first_quarter · Q1
Medicare payment for clinical diagnostics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148)(Section 3113); Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2012 · first_quarter · Q1
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORGANOGENESIS INC. via FOLEY HOAG LLP
2012 · first_quarter · Q1
Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment for drugs and biologics)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC via FOLEY HOAG LLP
2012 · first_quarter · Q1
Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); Domestic HIV Policy Issues; Hepatitis B Funding for Screening and Linkage to Care Programs; Budget Control Act of 2011(P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2012 · first_quarter · Q1
Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care Eduction Reconciliation Act of 2010 (Pub. L. 111-152)(Biosimilars); Budget Control Act of 2011 (P.L. 112-25).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via FOLEY HOAG LLP
2012 · first_quarter · Q1
Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2012 · first_quarter · Q1
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); Budget Control Act of 2011(P.L. 112-25).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2012 · first_quarter · Q1
Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)
Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act; Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION via FOLEY HOAG LLP
2012 · first_quarter · Q1
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2012 · first_quarter · Q1
Colorectal Cancer Medicare and Reimbursement Issues; Screen Act--S. 1511 Supporting Colorectal Examination Now Act; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152).
Medicare Reimbursement regarding SGR and ASC payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STATE OF THE USA via FOLEY HOAG LLP
2012 · first_quarter · 1T
Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Q4
Medicare payment for clinical diagnostics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148)(Section 3113); Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STATE OF THE USA via FOLEY HOAG LLP
2011 · fourth_quarter · Q4
Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERS HEALTHCARE SYSTEM via FOLEY HOAG LLP
2011 · fourth_quarter · Q4
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) (Delivery System Reforms)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ORGANOGENESIS INC. via FOLEY HOAG LLP
2011 · fourth_quarter · Q4
Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment for drugs and biologics)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2011 · fourth_quarter · Q4
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GILEAD SCIENCES INC via FOLEY HOAG LLP
2011 · fourth_quarter · Q4
Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); Domestic HIV Policy Issues; Hepatitis B Funding for Screening and Linkage to Care Programs; Budget Control Act of 2011(P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2011 · fourth_quarter · Q4
Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)(Biosimilars); Budget Control Act of 2011(P.L. 112-25).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via FOLEY HOAG LLP
2011 · fourth_quarter · Q4
Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DOVETAIL HEALTH via FOLEY HOAG LLP
2011 · fourth_quarter · Q4
Issues relating to Section 3026 of the Affordable Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2011 · fourth_quarter · Q4
H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2011 · fourth_quarter · Q4
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); Budget Control Act of 2011(P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2011 · fourth_quarter · Q4
Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act; Budget Control Act of 2011 (P.L. 112-25)
Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION via FOLEY HOAG LLP
2011 · fourth_quarter · Q4
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2011 · fourth_quarter · Q4
Colorectal Cancer Medicare and Reimbursement Issues; Screen Act--S. 1511 Supporting Colorectal Examination Now Act; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Medicare Reimbursement regarding SGR and ASC payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Q3
Medicare payment for clinical diagnostics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148)(Section 3113)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2011 · third_quarter · Q3
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARTNERS HEALTHCARE SYSTEM via FOLEY HOAG LLP
2011 · third_quarter · Q3
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) (Delivery System Reforms)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ORGANOGENESIS INC. via FOLEY HOAG LLP
2011 · third_quarter · Q3
Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC via FOLEY HOAG LLP
2011 · third_quarter · Q3
Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); Domestic HIV Policy Issues; Hepatitis B Funding for Screening and Linkage to Care Programs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2011 · third_quarter · Q3
FDA legislation and regulatory implementation issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via FOLEY HOAG LLP
2011 · third_quarter · Q3
Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)
H.R. 1249 America Invents Act of 2011; S. 23 Patent Reform Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DOVETAIL HEALTH via FOLEY HOAG LLP
2011 · third_quarter · Q3
Issues relating to Section 3026 of the Affordable Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2011 · third_quarter · Q3
Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2011 · third_quarter · Q3
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2011 · third_quarter · Q3
S. 23 Patent Reform Act of 2011.
Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act
Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)
AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION via FOLEY HOAG LLP
2011 · third_quarter · Q3
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2011 · third_quarter · Q3
Medicare Reimbursement regarding SGR and ASC payments.
Colorectal Cancer Medicare and Reimbursement Issues; Screen Act--S. 1511 Supporting Colorectal Examination Now Act; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED CELL TECHNOLOGY via FOLEY HOAG LLP
2011 · third_quarter · Q3
H.R. 4808 (Stem Cell Research Advancement Act of 2009)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DOVETAIL HEALTH via FOLEY HOAG LLP
2011 · third_quarter · RR
Issues relating to Section 3026 of the Affordable Care Act.
2011 · second_quarter · Q2
Medicare payment for clinical diagnostics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2011 · second_quarter · Q2
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE